A more recent study has found that the knockdown of MBTPS2 expression in human prostate cancer cells impaired cholesterol synthesis and uptake and reduced the expression of key regulators of fatty acid synthesis, FASN and ACACA, through SREBP signaling [77]. The gene discussed is FASN; the disease is prostate carcinoma.